• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; INTRODUCER, CATHETER Back to Search Results
Device Problem Difficult to Advance (2920)
Patient Problems Fistula (1862); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914)
Event Date 01/11/2024
Event Type  Injury  
Event Description
It was reported that a versacross access solution was selected for use during a watchman procedure.An excessive bleeding from the groin was noted, thus the procedure was cancelled.The transeptal access was gained using versacross.There was a narrowing of the common femoral vein so additional pressure was applied to get the sheath to advance.Once advanced, it was possible to successfully get transeptal puncture.When pulling the versacross sheath out, an excessive bleeding from the groin was noted and additional pressure was applied to slow blood flow down.The watchman access sheath and versacross dilator were inserted but unsuccessful at advancing past the narrowing in the cfv (common femoral vein).The sheath was removed, and left groin access was discussed.During this time the, the patient was still bleeding excessively so the decision was made to terminate the procedure.The patient remained stable but after about 30 minutes hemostasis was still not obtained and a slight drop in blood pressure was noted.An interventional radiology was called, and the patient was transported for a diagnostic ct (computed tomography).It was determined patient had an undiagnosed av (arteriovenous) fistula which was the result of the excessive bleeding.The patient did receive blood, and no intervention beyond that was required.The patient was discharged, and it is doing well.The device is not expected to be returned for analysis (disposed).The patient was admitted to hospital beyond standard of care.In the physician's opinion, the versacross rf wire and the versacross dilator did not contribute to the ae.There was kinking at the distal portion of the versacross rf wire once removed where the narrowing of the vessel was.No other issues were noted.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS ACCESS SOLUTION
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18656210
MDR Text Key334722514
Report Number2124215-2024-04349
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183655
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/11/2024
Initial Date FDA Received02/06/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexMale
Patient RaceWhite
-
-